Penn Medicine Co-Investment Program
University-based technology transfer and commercialization office that manages invention disclosures, intellectual property, licensing, corporate partnerships, startup formation, incubator programs, and university-affiliated funding to translate Penn research into commercial products and companies.
Industries
N/A
Nr. of Employees
Very Large (1000+)
Penn Medicine Co-Investment Program
3600 Civic Center Boulevard, 9th Floor, Philadelphia, PA 19104
Services
Assessment, patenting support, licensing negotiation, and commercialization strategy for university inventions, including marketing and outreach to potential partners.
Programs and advisory services for company formation, entrepreneur matching, early-stage operational support, and mentor/advisor networks.
Online portal and administrative support to submit, track, and manage invention disclosures and related documentation.
Customer-discovery workshops and cohort programs to validate market need and prepare teams for national customer-discovery programs and commercialization steps.
Administrative and legal support for negotiation and execution of CDAs, MTAs, SRAs, CRAs, data-use agreements, facility use agreements, and fee-for-service contracts.
Coordination and access to an incubator campus with lab/office space, coworking areas, and programmatic supports for startups including accelerator cohorts and mentor networks.
Assessment, patenting support, licensing negotiation, and commercialization strategy for university inventions, including marketing and outreach to potential partners.
Programs and advisory services for company formation, entrepreneur matching, early-stage operational support, and mentor/advisor networks.
Online portal and administrative support to submit, track, and manage invention disclosures and related documentation.
Customer-discovery workshops and cohort programs to validate market need and prepare teams for national customer-discovery programs and commercialization steps.
Administrative and legal support for negotiation and execution of CDAs, MTAs, SRAs, CRAs, data-use agreements, facility use agreements, and fee-for-service contracts.
Coordination and access to an incubator campus with lab/office space, coworking areas, and programmatic supports for startups including accelerator cohorts and mentor networks.
Expertise Areas
- Technology commercialization and licensing
- Intellectual property management and patent policy
- Research and industry contract negotiation
- Startup formation, acceleration and incubation
Key Technologies
- CRISPR gene editing
- Cell and gene therapy
- CAR-T and engineered T-cell therapies
- mRNA therapeutics and delivery platforms
News & Updates
Regular open office hours for Penn Engineering faculty, staff and students to discuss commercialization opportunities, IP questions, startup ideas, and corporate partnership aspirations.
Announcement of an AI-driven RNA biofoundry to accelerate AI-based RNA research and scale design and testing workflows.
Report on a personalized CRISPR gene-editing therapy administered by a clinical team at Penn Medicine and a pediatric hospital in collaboration.
Summary of awards and recognition for Penn-affiliated startups in regional ecosystem awards.
FY2025 metrics: #1 in licensing revenue for the fifth consecutive year; 650 commercialization agreements executed; ~400 new invention disclosures; 26 startups launched; >$591M raised by Penn-affiliated startups; 99 new patents awarded.
I-Corps site metrics: 163 teams since 2015 and $33M funds raised by teams participating in customer-discovery activities.
Regular open office hours for Penn Engineering faculty, staff and students to discuss commercialization opportunities, IP questions, startup ideas, and corporate partnership aspirations.
Announcement of an AI-driven RNA biofoundry to accelerate AI-based RNA research and scale design and testing workflows.
Report on a personalized CRISPR gene-editing therapy administered by a clinical team at Penn Medicine and a pediatric hospital in collaboration.
Summary of awards and recognition for Penn-affiliated startups in regional ecosystem awards.
FY2025 metrics: #1 in licensing revenue for the fifth consecutive year; 650 commercialization agreements executed; ~400 new invention disclosures; 26 startups launched; >$591M raised by Penn-affiliated startups; 99 new patents awarded.
I-Corps site metrics: 163 teams since 2015 and $33M funds raised by teams participating in customer-discovery activities.